Target intelligence / Profile preview

Plasma membrane H+-ATPase (PMA1) (PMA1)

Target
PMA1
Molecular classification
Transporter, Enzyme, P-type ATPase, Hydrolase
01

Overview

The fungal plasma membrane H+-ATPase (primarily Pma1p) is an essential P-type ATPase responsible for maintaining the electrochemical gradient across the fungal cell membrane (Serrano, 1989; UniProt P05030). By pumping protons out of the cytoplasm, it establishes a membrane potential and a pH gradient that are vital for the secondary active transport of nutrients such as amino acids and sugars (Monk et al., 1995). Because this pump is critical for fungal growth and survival and lacks a direct human ortholog, it represents a highly attractive target for the development of novel antifungal agents (Perlin et al., 1997). Inhibition of Pma1p leads to rapid intracellular acidification and metabolic collapse, effectively killing the fungal cell (Chan et al., 2017). Current research focuses on identifying small molecules, such as ebselen and certain cinnamic acid derivatives, that selectively bind to the fungal pump over human ion-transporting ATPases to minimize side effects (Nakamura et al., 1997; Billack et al., 2001).

Other names
P-type H+-ATPaseProton-translocating ATPasePma1pFungal proton pumpH+-transporting P-type ATPase
02

Mechanism of action

Inhibition of the P-type ATPase enzyme activity, preventing the extrusion of protons from the cytoplasm to the extracellular space. This leads to rapid intracellular acidification, dissipation of the membrane potential, and the subsequent cessation of secondary active transport of essential nutrients (Monk et al., 1995; Chan et al., 2017).

03

Biological functions

pH regulationMembrane potential maintenanceNutrient transportIon homeostasisCell growth
04

Disease associations

InfectionCandidiasisAspergillosisCryptococcosisSystemic mycosis
05

Safety considerations

Cross-reactivity with human P-type ATPases such as Na+/K+-ATPase and gastric H+/K+-ATPasePotential for systemic toxicity if selectivity for the fungal isoform is insufficientOff-target effects on mitochondrial ATP synthases
06

Interacting drugs

Ebselen

6 more in the full profile.

07

Biomarkers

Intracellular pH (pHi)Extracellular acidification rate (ECAR)Cytoplasmic ATP/ADP ratioFungal cell viability

Beyond the preview

Go deeper on Plasma membrane H+-ATPase (PMA1) (PMA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma membrane H+-ATPase (PMA1) (PMA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call